COVID-19 SYMPTOMS AT HOSPITAL ADMISSION VARY WITH AGE AND SEX: Results from the ISARIC prospective multinational observational study

ISARIC Clinical Characterisation Group

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

56 Citas (Scopus)

Resumen

Background: The ISARIC prospective multinational observational study is the largest cohort of hospitalized patients with COVID-19. We present relationships of age, sex, and nationality to presenting symptoms. Methods: International, prospective observational study of 60 109 hospitalized symptomatic patients with laboratory-confirmed COVID-19 recruited from 43 countries between 30 January and 3 August 2020. Logistic regression was performed to evaluate relationships of age and sex to published COVID-19 case definitions and the most commonly reported symptoms. Results: ‘Typical’ symptoms of fever (69%), cough (68%) and shortness of breath (66%) were the most commonly reported. 92% of patients experienced at least one of these. Prevalence of typical symptoms was greatest in 30- to 60-year-olds (respectively 80, 79, 69%; at least one 95%). They were reported less frequently in children (≤ 18 years: 69, 48, 23; 85%), older adults (≥ 70 years: 61, 62, 65; 90%), and women (66, 66, 64; 90%; vs. men 71, 70, 67; 93%, each P < 0.001). The most common atypical presentations under 60 years of age were nausea and vomiting and abdominal pain, and over 60 years was confusion. Regression models showed significant differences in symptoms with sex, age and country. Interpretation: This international collaboration has allowed us to report reliable symptom data from the largest cohort of patients admitted to hospital with COVID-19. Adults over 60 and children admitted to hospital with COVID-19 are less likely to present with typical symptoms. Nausea and vomiting are common atypical presentations under 30 years. Confusion is a frequent atypical presentation of COVID-19 in adults over 60 years. Women are less likely to experience typical symptoms than men.

Idioma originalInglés
Páginas (desde-hasta)889-905
Número de páginas17
PublicaciónInfection
Volumen49
N.º5
DOI
EstadoPublicada - 25 jun. 2021

Nota bibliográfica

Publisher Copyright:
© 2021, The Author(s).

Financiación

FinanciadoresNúmero del financiador
EU Platform for European Preparedness Against
HPRU
Irish Critical Care Trials Group
McGill Interdisciplinary Initiative in Infection and Immunity
NIHR Biomedical Research Centre at Imperial College LondonIS-BRC-1215-20013
National Institutes of Health
Bill and Melinda Gates FoundationOPP1209135
Astellas Pharma US
GlaxoSmithKline
Merck
Roche
Procter and Gamble
Baxter International
Gilead Sciences
National Center for Advancing Translational SciencesUL1TR002240
Boehringer Ingelheim
Merck Sharp and Dohme
Wellcome Trust215091/Z/18/Z
Seventh Framework Programme602525
UK Research and Innovation2014047.1
Gilead UK and Ireland Corporate Contributions
Imperial Experimental Cancer Medicine CentreC18616/A25153
National Institute for Health Research Health Protection Research Unit
Canadian Institutes of Health ResearchOV2170359
Medical Research CouncilMC_PC_19059
National Institute for Health and Care ResearchCO-CIN-01
Department for International Development, UK Government
Imperial College London200927
Oxford University200907
Health Research Board2014-012
Public Health England
Norges Forskningsråd312780
Prince Charles Hospital Foundation

    Huella

    Profundice en los temas de investigación de 'COVID-19 SYMPTOMS AT HOSPITAL ADMISSION VARY WITH AGE AND SEX: Results from the ISARIC prospective multinational observational study'. En conjunto forman una huella única.

    Citar esto